SEVERE PREECLAMPSIA IN PRETERM PREGNANCY BETWEEN 26 AND 32 WEEKS GESTATION

被引：24

作者：

BANIAS, BB ^{[1
]}

DEVOE, LD ^{[1
]}

NOLAN, TE ^{[1
]}

机构：

[1] MED COLL GEORGIA,DEPT OBSTET & GYNECOL,MATERNAL FETAL MED SECT,AUGUSTA,GA 30912

来源：

AMERICAN JOURNAL OF PERINATOLOGY | 1992年 / 9卷 / 5-6期

关键词：

D O I：

10.1055/s-2007-999264

中图分类号：

R71 [妇产科学];

学科分类号：

100211 [妇产科学];

摘要：

Obstetric management of severe preeclampsia between 26 and 32 weeks' gestation presents a significant management dilemma. We examined the antenatal courses and perinatal outcomes of 67 such affected pregnancies and compared them with a group of 134 patients, matched for gestational age, who delivered after preterm rupture of membranes or preterm labor. Although the severe preeclamptic group had more patients with chronic hypertension and renal disease, 67% had no prior medical problems. The obstetric and other medical characteristics of both groups were similar. Neonatal outcomes in the severe preeclampsia group differed from those in the control group: they had lower mean birthweight, 5-minute Apgar score and umbilical arterial pH were lower, and their rates of respiratory distress syndrome and perinatal death were higher. Temporization for more than 72 hours was not possible in 60 of 67 preeclamptic pregnancies due to rapid deterioration of the mother (56 cases) or fetus (4 cases). The rate of poor neonatal outcomes in severe preeclampsia exceeded that expected with preterm delivery alone and may reflect preexisting fetal compromise, served better by early intervention and delivery.

引用

页码：357 / 360

页数：4

共 10 条

[1]

Pritchard J.A., Management of severe preeclampsia and eclampsia, Semin Perinatol, 2, pp. 83-97, (1978)

[2]

Sibai B.M., Taslimi M., Abdella T.N., Brooks T.F., Spinnato J.A., Anderson C.D., Maternal and perinatal outcome of conservative management of severe preeclampsia in mid-trimester, Am J Obstet Gynecol, 152, pp. 32-37, (1988)

[3]

Sibai B.M., Mabie B.C., Harvey C.J., Gonzalez A.R., Pulmonary edema in severe preeclampsia-eclampsia: Analysis of thirty-seven consecutive cases, Am J Obstet Gynecol, 156, pp. 1174-1179, (1987)

[4]

Sibai B.M., Spinato J.A., Watson D.L., Hill G.A., Anderson G.D., Pregnancy outcome in 303 cases with severe preeclampsia, Obstet Gynecol, 64, pp. 319-325, (1984)

[5]

Sibai B.M., Sherif A., Fairlie F., Moretti M., A protocol for managing severe preeclampsia in the second trimester, Am J Obstet Gynecol, 163, pp. 733-738, (1990)

[6]

Merrill T.A., Hallman M., Spragg R., Heldt G.P., Gilliard N., Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome, Drugs, 38, pp. 591-611, (1989)

[7]

Giles W., Trudinger B., Baird P., Fetal umbilical artery How velocity waveforms and placental resistance: Pathological correlation, Br J Obstet Gynecol, 92, pp. 31-38, (1985)

[8]

Ricke P.S., Elliott J.F., Freeman R.K., Use of corticosteroids in pregnancy-induced hypertension, Obstet Gynecol, 55, pp. 200-210, (1980)

[9]

Schiff E., Peleg E., Goldenberg M., Et al., The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies, N Engl J Med, 321, pp. 351-357, (1989)

[10]

Benigni A., Gregorini G., Frusca T., Et al., Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension, N Engl J Med, 321, pp. 357-362, (1989)

← 1 →